Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients

Clarithromycin-based triple therapy for Helicobacter pylori treatment in peptic ulcer patients

Introduction: The scheme proton pump inhibitor/amoxicillin/clarithromycin (PPI/AC) is still the first-line treatment for Helicobacter pylori (H. pylori) infections despite evidence suggesting its failure in up to 20% to 30% of patients. Methodology: This study involved 493 patients who were presc...

Full description

Saved in:
Bibliographic Details
Main Authors: Guilherme Felga, Fernando Marcuz Silva, Ricardo Correa Barbuti, Tomas Navarro-Rodriguez, Schlioma Zaterka, Jaime Natan Eisig
Format: Article
Language:English
Published: The Journal of Infection in Developing Countries 2010-07-01
Series:Journal of Infection in Developing Countries
Subjects:
Helicobacter pylori
peptic ulcer disease
treatment
Online Access:https://jidc.org/index.php/journal/article/view/911
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://jidc.org/index.php/journal/article/view/911

Similar Items